関連する実験動画
Updated: Sep 21, 2025

08:00
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
Published on: May 26, 2021
13.0K
ヒトの生涯における血液形成のクローン動態
Emily Mitchell1,2,3, Michael Spencer Chapman1, Nicholas Williams1
1Wellcome Sanger Institute, Hinxton, UK.
Nature
|June 1, 2022
まとめ
老化するヒトは,血液形成幹細胞 (HSC/MPP) の多様性が減少したため,血液細胞の生産が急激に低下します. この年齢に関係する変化は 既知の癌の原動力ではなく 変異に作用する ポジティブ・セレクションによって引き起こされます
科学分野:
- 血液学
- ゲノミクス
- 老化に関する研究
背景:
- 人間の血液形成の年齢関連の変化は,再生能力の低下,細胞減少,免疫機能障害,癌のリスクの増加につながる.
- 70歳以降の急激な機能低下の根本的な原因は不明である.
研究 の 目的:
- ヒトの血液形成のゲノムとクローンダイナミクスを研究する.
- 高齢者の血液形成機能の低下と血液がんのリスクの増加の原因を理解する.
主な方法:
- 10人のヒト (0~81歳) の単細胞由来細胞コロニーの3,579個のゲノムをシーケンシングした.
- 遺伝子変異の蓄積,テロメアの長さ,および血液形成性幹細胞または多能幹細胞 (HSC/MPP) のクローン多様性の分析.
- ゲノム全体の選択分析とシミュレーションで血液形成の変化をモデル化する.
主要な成果:
- HSC/MPPは変異を蓄積し,年齢とともにテロメアの長さを失う.
- 65歳未満の成人は高クローン多様性を持つポリクローン血球形成を示します.
- 75歳以上の個体ではクローン多様性が著しく低下し,血液形成を主導するクローンは少数で,しばしばドライバ変異は知られていない.
- 陽性選択は多数の非同義性変異に作用し,Y染色体の喪失が男性に利点をもたらします.
結論:
- クローン多様性の急速な減少は 人間の老化における普遍的な特徴です
- 既知の癌の誘発因子を超えて 多くの遺伝子に浸透したポジティブ・セレクションが この年齢に関連するクローン構造の変化の根底にあるのです
- シミュレーションは,恒常的な幹細胞集団とドライバー変異が,高齢者の観察された変化を説明することを支持しています.
関連する概念動画
Overview of Hematopoiesis
4.9K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
4.9K
Hematopoiesis
5.7K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.7K
Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
Production of Formed Elements
1.8K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
1.8K
Multipotency of Hematopoietic Stem Cells
3.3K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.3K
Lineage Commitment
3.3K
Commitment is the process whereby stem cells:
3.3K

